Part 7 Stricter Post-market Surveillance Requirements and MAH’s Responsibilities Under Order 739

This session of the webinar introduces the Stricter post-market surveillance requirements and MAH’s responsibilities under order 739. In this section,the speaker mainly around the Adverse events to expalin. It divided into MAH responsibility, reporting management under Oder 739, adverse events self inspection report, etc.

Suggested Reading

UK-China Medical Device Access to China Webinar: Session 1-Navigating Medical Device Lifecycle and Compliance in China
UK-China Medical Device Access to China Webinar: Session 2 - Targeting Unmet Medical Needs in China's Growing Market

Previous: Part 6 Comparing CER Draft vs Final Guidance

Next: Part 1 Introduction the Webinar——Keep up with the Enhancement of Medical Device Post-Market Surveillance in China: GMP, GSP, and NMPA onsite inspections

Part 7 Stricter Post-market Surveillance Requirements And MAH’s Responsibilities Under Order 739

Suggested Reading